Eucalyptus

Eucalyptus is a Sydney, Australia-based digital health company that operates direct-to-consumer telehealth clinics providing online medical consultations and targeted prescription deliveries. The platform currently supports over 500,000 patients across five international markets through its specialized digital clinics, which include Pilot for men's health and Juniper for women's weight management. The organization expanded its market presence by acquiring the digital assets of Jenny Craig Australia in 2023, and was subsequently acquired by Hims & Hers Health for up to $1.15 billion in February 2026. Prior to this major acquisition, the enterprise reached a $560 million valuation following a $50 million funding round, backed by prominent institutional investors such as Blackbird Ventures and Woolworths. Eucalyptus was originally founded in 2019 by the entrepreneurial team of Tim Doyle, Charlie Gearside, Benny Kleist, and Alexey Mitko.

Eucalyptus is a healthcare technology company founded in 2019 that builds and operates a vertically integrated telehealth platform delivering personalized digital healthcare experiences for patients. It serves over 200,000 patients primarily in Australia, the UK, Germany, and Japan through multiple specialized brands addressing obesity (Juniper), men’s health (Pilot), women’s fertility and contraception (Kin), skincare (Software), and sexual wellness (Normal). Eucalyptus’s platform connects telehealth consultations, pharmacy delivery, and ongoing care to solve chronic and demographic-specific health challenges, enabling better patient outcomes and higher engagement across its services[1][2][3].

The company’s mission is to fix the broken healthcare system by providing accessible, high-quality care that addresses rising chronic conditions like obesity and diabetes through a scalable digital model. Eucalyptus has demonstrated strong growth momentum with over one million consultations facilitated, significant weight loss outcomes for patients, and cost savings to healthcare systems. Its vertically integrated platform allows rapid launch and scaling of new brands and features, driving customer retention and expanding usage over time[2][6].

---

Origin Story

Eucalyptus was founded in 2019 in Sydney, Australia, by a team focused on transforming healthcare delivery through technology. The idea emerged from recognizing the inefficiencies and access barriers in traditional healthcare, especially for chronic and demographic-specific conditions. Early traction came from launching multiple digital health brands that leveraged a shared technology platform, enabling efficient operations and rapid expansion. This foundation allowed Eucalyptus to become Australia’s largest vertically integrated telehealth platform within a few years, serving hundreds of thousands of patients and expanding internationally[1][2][3].

---

Core Differentiators

• Vertically Integrated Platform: Eucalyptus operates a shared technology and operational backend across all its brands, enabling seamless integration of telehealth, pharmacy, and ongoing care services.
• Demographic- and Condition-Specific Brands: Focused brands like Juniper (weight management), Kin (fertility and contraception), and Software (skincare) provide tailored, high-touch digital healthcare experiences.
• Scalable Infrastructure: New features and brands can be rapidly launched and scaled across the platform, increasing efficiency and customer retention.
• Strong Clinical Governance: Over one million consultations with a stellar patient safety record built on robust clinical protocols.
• Global Reach: Active in multiple countries, expanding access to quality care beyond Australia.
• Data-Driven Outcomes: Demonstrated impact on patient health, including significant weight loss and chronic disease diagnosis, alongside healthcare cost savings[1][2][3][4][6].

---

Role in the Broader Tech Landscape

Eucalyptus rides the global trend toward digital transformation in healthcare, particularly telehealth and personalized medicine. The timing is critical as chronic diseases like obesity and diabetes rise worldwide, and healthcare systems face pressure to improve access, reduce costs, and enhance patient engagement. Eucalyptus’s vertically integrated model addresses these market forces by combining technology, clinical care, and pharmacy services in one platform, enabling proactive chronic disease management and behavioral health support. This approach influences the broader ecosystem by setting a new standard for scalable, patient-centered digital healthcare delivery[2][6].

---

Quick Take & Future Outlook

Looking ahead, Eucalyptus is poised for exponential growth by expanding its portfolio to address more complex chronic conditions and new demographic segments globally. Trends such as increasing telehealth adoption, demand for personalized care, and digital health integration will shape its journey. The company’s scalable platform and strong clinical foundation position it to deepen its influence on healthcare delivery models, potentially becoming a global leader in condition-specific digital health ecosystems. Continued innovation in technology and care pathways will be key to sustaining momentum and expanding impact[2][6].

Eucalyptus exemplifies how technology can fix systemic healthcare challenges by delivering accessible, effective, and personalized care that lasts a lifetime.